Patents Assigned to Roche Diabetes Care, Inc.
  • Patent number: 11406758
    Abstract: A first connector part (110) for establishing a fluid connection with a second connector part comprises a valve (111) with a valve seat (112), the valve seat comprising a valve chamber (116) and a circular opening with a circumferential sealing lip (114); a valve member (113), the valve member being provided in the valve chamber, and being able to sealingly close the circular opening of the valve seat when being pushed against the circular opening; and a resilient element (115) that subjects the valve member to a bias force pushing the valve member against the circular opening of the valve seat. The valve member further comprises a circumferential wall around the circular opening, located on a side of the circular opening opposite to the valve chamber.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: August 9, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventor: Hans List
  • Patent number: 11408881
    Abstract: A test meter and method for detecting the presence and/or concentration of an analyte in a liquid biological sample. The meter includes an internal cavity receiving a test strip. A pressure sensor is arranged and configured to sense a pressure exerted by the inserted test strip relative to the meter housing. A controller receives signals corresponding to the sensed pressure, compares the signal to a pressure threshold value, and indicates when the sensed pressure exceeds the pressure threshold value. The method is for detecting the application of an undue pressure applied against a test strip relative to a meter, and includes receiving a test strip in a meter in a position adjacent a pressure sensor, using the sensor to sense the pressure applied by the inserted test strip relative to the meter, and comparing the sensed pressure to a predetermined threshold value.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: August 9, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventor: Benhur Aysin
  • Patent number: 11406757
    Abstract: Disclosed is a method for scheduling a refilling of a secondary reservoir of an ambulatory infusion system out of a primary reservoir storing a liquid drug. The method includes repeatedly and automatically carrying out a filling volume assessment routine. The filling volume assessment routine includes: determining, at a present point in time, an estimated filling volume of the secondary reservoir at a future estimation point in time, the future point in time being an estimation time interval after the present point in time, and determining in dependence of the estimated filling volume, if the secondary reservoir shall be refilled at the present point in time.
    Type: Grant
    Filed: February 8, 2020
    Date of Patent: August 9, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Kurt Friedli, Stefan Pfalz
  • Patent number: 11406296
    Abstract: A system and method is provided for analyzing a glucose state. A method may include identifying a target glucose state and an initial glucose state. The method may include calculating a target return path for a transition from the initial glucose state to the target glucose state. The target return path may comprise at least one intermediate glucose state associated with the transition from the initial glucose state to the target glucose state. The target return path may be calculated based on a hazard associated with the at least one intermediate glucose state of the target return path.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: August 9, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: David L. Duke, Abhishek S. Soni
  • Patent number: 11399753
    Abstract: An electrochemical sensor is disclosed. The sensor has a substrate having a proximal part and an elongated distal part. Electrodes are formed on the distal part. The working electrode forms a conductive trace and multiple electrode pads are arranged along and connected by conductive trace. The electrode pads include a corrosive conductive layer covered by a non-corrosive conductive layer. The corrosive conductive layer is a metal less noble or as noble as Ag, and the non-corrosive conductive is a metal more noble than Ag. An insulating layer on the substrate has openings in the areas of the electrode pads. A protective measure for the corrosive conductive layer can be provided, such as having the insulating layer at least partially overlap the electrode pad edges, or providing at least one of the electrode pads with an elongated shape along the smaller dimension of the distal part.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: August 2, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Sabine Achmann, Stephan-Michael Frey, Sebastian Pankalla
  • Patent number: 11399754
    Abstract: A medical device for transcutaneously inserting an insertable element into a body tissue. The medical device includes an insertable element that has an in vivo distal end for subcutaneous insertion, an ex vivo proximal end, and a pre-bended insertion cannula for subcutaneously inserting the insertable element. The medical device further comprises at least one patch, which is configured to be mounted on the skin of a user. The patch has a patch base and an integrated insertion mechanism for driving the insertion cannula from a storage position within the patch into an inserted position within the body tissue on a curved insertion path.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: August 2, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Joachim Jäger
  • Publication number: 20220239636
    Abstract: A method for operating a medical system includes providing a public-private key pair for asymmetric cryptography, wherein the public key is provided to remote control and medical devices, and the private key is provided to a security module, encrypting a control command with the public key in the remote control, receiving the encrypted control command in the security module, decrypting the encrypted control command with the private key, encrypting a security module control command with the private key applied to the decrypted control command or an amended medical control command derived from the decrypted control command, receiving the security module control command in the medical device, decrypting the security module control command with the public key, and controlling operation of the medical device according to the decrypted security module control command, if confirmed by a user confirmation input received in the security module or the medical device.
    Type: Application
    Filed: April 12, 2022
    Publication date: July 28, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Andreas Kreuzer
  • Publication number: 20220236208
    Abstract: A hybrid analyte test meter includes a processor operatively connected to a memory, measurement signal generator, measurement signal receiver, and short range wireless transceiver. The processor executes firmware instructions in the memory to operate the measurement signal generator to apply electrical signals to a sample deposited on the electrochemical test strip via the port, receive signal measurements from the measurement signal receiver in response to the predetermined sequence of electrical signals, and transmit data corresponding to the plurality of signal measurements to an external computing device using the short range wireless transceiver, wherein the processor does not identify a measurement of an analyte in the sample based on the plurality of signal measurements.
    Type: Application
    Filed: April 12, 2022
    Publication date: July 28, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Scott E. Carpenter
  • Patent number: 11395608
    Abstract: A medical sensor system comprising a sensor implantable under the skin of a user and an on-body module attachable to the skin in the region of the implantable sensor, wherein the on-body module has a self-adhering flexible electronics patch including a first transmitter which is operable to exchange data with the implantable sensor via a short-range wireless connection.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: July 26, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Oliver Kube, Helmut Walter, Alexander Poggenwisch
  • Publication number: 20220229818
    Abstract: A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.
    Type: Application
    Filed: April 8, 2022
    Publication date: July 21, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: P. Douglas Walling, Juergen Rasch-Menges, Stefan Weinert, Steven Bousamra, Abhishek S. Soni, Christoph Eisenhardt
  • Patent number: 11389586
    Abstract: Disclosed is a supervision device (9) for supervising liquid drug flow in a flow channel (20). The supervision device (9) includes a flow detector (1), arranged for operatively coupling with the flow channel (20) and generating a flow detector signal in dependence of a flow in the flow channel (20) at a flow detection location. The supervision device (9) further includes a gas detector (8), arranged for operatively coupling with the flow channel (20) and generating a gas detector signal in dependence of whether liquid drug or gas is present in the flow channel (20) at a gas detection location at a distance upstream from the flow detection location.
    Type: Grant
    Filed: September 4, 2017
    Date of Patent: July 19, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Hans List, Frederic Wehowski
  • Patent number: 11391715
    Abstract: Coating compositions are described that include one or more rare metal components, such as rare alkali metal components, as well as diagnostics test elements that incorporate the same. Methods also are described for determining an amount of a dried coating composition in a coat based upon the rare metal components.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: July 19, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Wolfgang Schick, Alexander Ibach, Yilmaz Isgoeren, Kai Kuellmer
  • Patent number: 11382507
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: July 12, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Patent number: 11369319
    Abstract: The disclosure refers to a method of operating a receiver for receiving analyte data from a biosensor monitoring an analyte by detecting analyte values, the method comprising: in a receiver (1), receiving analyte values detected by a biosensor (8) monitoring an analyte in intervals of time for which a first interval time is applied; receiving a present analyte value in the receiver (1); providing a rate of change for the analyte values; determining a future analyte value based on the present analyte value, the first interval time, and the rate of change; providing an analyte value range for the analyte values; setting a second interval time, the second interval time being shorter than the first interval time, if the future analyte value is outside the analyte value range, and longer than or equal to the first interval time, if the future analyte value is within the analyte value range; and in the receiver (1), receiving one or more following analyte values in intervals of time for which the second interval ti
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: June 28, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Kai-Oliver Schwenker, Carsten Mueglitz, Andreas Huber-Toth, Felix Bootz
  • Patent number: 11363991
    Abstract: A computer-implemented method and a system for analyzing glucose monitoring data indicative of a glucose level, comprising: presenting by a data processing device provided a graphical window on a display device wherein the graphical window comprises a time abscissa axis that defines time units, and a glucose ordinate axis that defines glucose units; receiving a plurality of glucose monitoring values associated with a monitoring time period by the data processing device; segmenting the plurality of glucose monitoring values into a plurality of glucose monitoring traces indicative of the glucose level; defining a reference trace segment; determining the reference trace segment for each of the plurality of glucose monitoring traces; and plotting, for a time window comprising the reference trace segment, the plurality of glucose monitoring traces within the graphical window. Furthermore, a non-transitory computer readable medium is disclosed.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: June 21, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Matthias Koehler, Bernd Steiger, Timm Wiedemann
  • Patent number: 11350821
    Abstract: An ambulatory medical device and a method of communication between medical devices are disclosed. In one embodiment, the medical device includes a module for communication with at least a second medical device wherein the module for communication is adapted to be activated by a value of a physiological parameter of an animal. In one embodiment, the method of the present invention involves a first medical device and at least a second medical device wherein the communication between said medical devices is activated by a value of a physiological parameter of an animal.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: June 7, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Matthias Essenpreis, Ulrich Haueter, Nicole Bernini, Sybille Fankhauser, Sebastiaan La Bastide, Gunnar Meyer Olden, Michael Schoemaker, Kelly Heaton, Joel Jeckelmann
  • Patent number: 11350822
    Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: June 7, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Erica Diebold
  • Patent number: 11346852
    Abstract: This disclosure concerns a method and a system for quality evaluation of a handheld analytical device, wherein the device is operable by a human user in a sequence of handling steps to test an analyte in a sample fluid applied on a test element, the method comprising the steps of (a) programming a handling cycle for a robot having at least one robot arm in order to mimic the sequence of handling steps, (b) operating the device in at least one handling cycle by means of the robot, (c) monitoring the operation in step (b) by a control unit to evaluate at least one parameter influencing the quality of the device.
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: May 31, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Wolfgang Schwoebel
  • Patent number: 11342056
    Abstract: A method for characteristic monitoring in conjunction with a mode of continuously measured blood glucose values, in a monitor apparatus provided with a processor, a memory, a data interface, an input device, and a signaling device, the method comprising: providing a first set of event specific characteristics assigned to a first event, the first set of event specific characteristics being different from a second set of event specific characteristics assigned to a second event which is different from the first event, receiving blood glucose value data performing a safety check by comparing the first set of event specific characteristics to present characteristics derived from the blood glucose value data and/or the characteristic values, generating a warning signal or generating a safety signal, and outputting an output signal. A monitor apparatus is also disclosed.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: May 24, 2022
    Assignee: Roche Diabetes Care Inc.
    Inventors: Bernd Steiger, Juergen Rasch-Menges
  • Patent number: 11337891
    Abstract: The invention concerns a reservoir (1) for storing a liquid medicament. The reservoir (1) comprises a flexible container (10) which includes one folding layer (12), wherein the folding layer (12) includes a seam (13) which provides for a sealing of the flexible container (1). The reservoir comprises a rigid part (20) which is connected to the flexible container (10) and which includes a support (25) extending into the flexible container (10) and which includes one or more ports (21, 22) providing fluidic access to the flexible container (10). The reservoir comprises a porous hydrophilic membrane (26) which is connected to the support (25) of the rigid part (20). The invention further concerns a method for producing of a reservoir (1).
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: May 24, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Wilhelm Leichner, Hans List